drugset / Trial / NCT04357002

Intravenous Tranexamic Acid Versus Vaginal Dinoprostone in Abdominal Myomectomy

NCT04357002

Phase 4 Unknown 180 enrolled Cairo University
RandomizedParallel-groupQuadruple-blindTreatment

Summary

the aim of the present study is to evaluate safety and efficacy of intravenous tranexamic acid versus vaginal dinoprostone in reducing intraoperative blood loss during abdominal myomectomy

Timeline

Start
2020-04-30
Primary completion
2020-10-01
Completion
2020-10-15

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dinoprostone Other / unclassified 3 mg Intravitreal
Subject Tranexamic Acid Small molecule 15 mg/kg Intravenous

Indications